There were no significant differences of Shh, Ptch1, Smo, Gli1 mRNA expression found when comparing CML patients of chronic phase(CP) with imatinib(IM) treated or not(p > 0.05). Here, SHH is linked to chronic myelogenous leukemia, BCR-ABL1 positive.